Viva Cyte Sehatra Rindrambaiko Suite nataon'i Livia Stevenin

Ny endrika Viva Cyte Sehatra Rindrambaiko Suite nataon'i Livia Stevenin dia mpandresy sarobidy amin'ny 2025 A' Design Award Volafotsy amin'ny Sokajin'ny Fifanintsanana Famolavolana Serasera, Fifandraisana ary Traikefan'ny Mpampiasa.

VolafotsySerasera· 2025

Viva Cyte Sehatra Rindrambaiko Suite

nataon'i Livia Stevenin

Mpanjifa: Cellply

Mpandresy A' Design Award Volafotsy amin'ny Sokajy Serasera

56,621

Mpandresy Loka Voamarina

Hanamarina ny Sata Loka ho an'ny #168358

Tsidiho ny Tranonkala Jereo ao amin'ny A' Design Award Fanambarana ho an'ny Mpanao Gazety Marika Loka

Loko

Ny Endrika

Momba ny Viva Cyte Sehatra Rindrambaiko Suite

Viva Cyte dia sehatra rindrambaiko mandroso natao hanamora ny fivoarana ny fitsaboana amin'ny sela amin'ny alalan'ny fampidirana automatisation, famakafakana throughput avo, ary traikefa mora takatra ho an'ny mpampiasa. Misy ny Rindrambaiko Mpanara-maso (CSW) hitantanana ny fitsapana biolojika sy ny Rindrambaiko Famakafakana (ASW) haka tombontsoa manan-danja. Ny automatisation mifototra amin'ny AI dia mampihena ny fahadisoana ataon'ny olombelona, manatsara ny fahamarinana, ary manatsara ny fahamora-mampiasa azy, ka ahafahan'ny mpikaroka mitantana ny fizotry ny asa sarotra amim-pahombiazana sady manafaingana ny fandrosoana ara-pitsaboana.

Ny Fankasitrahana

Momba ny A' Design Award Volafotsy

Nandresy ny A' Design Award Volafotsy ny famolavolana Viva Cyte Sehatra Rindrambaiko Suite, fankasitrahana malaza be omena ny famolavolana ambaratonga ambony, tsara tarehy ary mahavariana. Ny mpandresy Volafotsy dia asa mamirapiratra dia mamirapiratra ary mamorona dia mamorona izay maneho ny fahaizana, ny talenta ary ny fahamaotinan-tsain'ny mpamolavola azy. Andrasana ho asa mahagaga, ohatra tsara, mahay amin'ny asa ary vaovao amin'ny halalin-tsaina ny famolavolana Viva Cyte Sehatra Rindrambaiko Suite. Ity famolavolana nandresy ny A' Design Award Volafotsy ity dia fikarohana miavaka be ary ankafizina izay mahasoa ary mampandroso ny sisintanin'ny zavakanto, ny siansa, ny famolavolana ary ny teknolojia. Ny famolavolana Viva Cyte Sehatra Rindrambaiko Suite dia famoronana mahazo fitaka be izay mamaly ny faniriana, mitondra fihetseham-po tsara ary mamelona fahagagana sy fahatalanjonana.

Ao Ambadiky ny Endrika

Fitaovana ho an'ny Mpanao Gazety

Fankasitrahana, mpikambana ao amin'ny ekipa ary antsipiriany teknika nomen'ny mpanao endrika.

Toetra Manokana: The project focused on UX/UI design for two integrated software solutions: Control Software (CSW) for launching and managing biological tests and Analytical Software (ASW) for extracting key insights from results. The design prioritizes scalability, usability, and automation and enables researchers to navigate complex workflows, configure tests, and analyze data with minimal effort, streamlining the entire process.
Refy & Fonosana: Design: Figma
Front-end: React JS
Design System: Bento
Marika: Cell therapy software, AI-driven automation, biomedical research, UX/UI design, data-driven, workflow optimization, healthcare innovation, regulatory compliance, user-centered design
Teknolojia Famokarana: We conducted extensive user research to design VivaCyte's software suite, including shadowing biologists in labs and interviewing end-users to understand their workflows and challenges. We also organized User Journey Mapping workshops, bringing together biologists and development teams to foster collaboration and gather diverse perspectives. The insights from these activities guided the creation of a custom design system, ensuring consistency and usability across the platforms.
Fanamby Endrika: Designing VivaCyte posed challenges in balancing usability, automation, and compliance. Internally, we had to align complex biological workflows with intuitive design, ensuring seamless lab adoption. Externally, strict medical regulations require adherence to compliance standards. Limited industry precedents and evolving AI capabilities pushed us to innovate with user research, iterative prototyping, and AI-driven automation, overcoming barriers in technology and regulatory constraints.
Fikarohana: We conducted user research to enhance VivaCyte’s usability and efficiency. Using shadowing and interviews, we observed lab workflows and identified pain points. Data was collected via on-site studies, journey mapping, and prototype testing with biologists and technicians. Insights led to features like printable maps and a guided setup walkthrough, reducing errors and improving efficiency. The research optimized workflows, accelerating cell therapy development.
Aingam-panahy: Inspired by the need to accelerate cancer cell therapies, VivaCyte was designed to streamline workflows, reduce human error, and enhance patient care. Recognizing the challenges of complex, labour-intensive workflows in cell therapy development, we sought to create a solution that integrates advanced automation, high-throughput analysis, and intuitive design. The design prioritizes usability and scalability, enabling researchers and clinicians to focus on innovation rather than constraints.
Faharetan'ny Tetikasa: The project started in January 2022 in Milan and finished in August 2024.
Fizotr'asa: VivaCyte streamlines cell therapy workflows through an intuitive, automated interface. Users launch tests via the Control Software (CSW), which configures experiments that can be followed in real-time, while the Analytical Software (ASW) extracts biological insights and displays them. AI-driven automation minimizes errors, ensuring accuracy and efficiency. Designed for seamless interaction, it simplifies complex tasks, accelerates data analysis, and enhances usability.
Mpikambana ao amin'ny Ekipa: Designer: Sara Bianchini
Designer: Livia Stevenin
Designer: Agnese Ragucci
Loharanon-tsary: Image #1: Mockup: Designed by Freepik, Image: Livia Stevenin (UX/UI designer), Image #2: Livia Stevenin (UX/UI designer), Image #3: Livia Stevenin (UX/UI designer), Image #4: Livia Stevenin (UX/UI designer), Image #5: Livia Stevenin (UX/UI designer),